生活方式改变对严重高总胆固醇(> 14 mmol/L)和甘油三酯(> 40 mmol/L)患者的治疗

Janhavi Patel, Tanmya Sharma, Connor Allan, Gregory Curnew
{"title":"生活方式改变对严重高总胆固醇(> 14 mmol/L)和甘油三酯(> 40 mmol/L)患者的治疗","authors":"Janhavi Patel,&nbsp;Tanmya Sharma,&nbsp;Connor Allan,&nbsp;Gregory Curnew","doi":"10.15280/jlm.2021.11.1.43","DOIUrl":null,"url":null,"abstract":"<p><p>In this report, we describe a case of a 37-year old man who presented with a history of total cholesterol > 14 mmol/L and triglyceride levels > 40 mmol/L. The patient was initially thought to have familial hypercholesterolemia due to his elevated total cholesterol, by his family physician. He was prescribed evolucumab, a proprotein convertase subtilisin/ kexin type 9 inhibitor drug which has shown efficacy for lowering low-density lipoprotein-cholesterol levels, to reduce his high total cholesterol. However, in this patient, the elevated total cholesterol was likely due to hypertriglyceridemia, rather than increased low-density lipoprotein-cholesterol levels. Through this case we provide an approach for the clinical management of patients with elevated total cholesterol with underlying triglycerides ≥ 10 mmol/L. The primary intervention for management of triglycerides ≥ 10 mmol/L involves lifestyle modifications including, changes in diet, exercise, reduction in body mass index, and abstinence from alcohol consumption. Secondary intervention involves management through pharmacotherapy with fibrates and statins. Creating a plan of action with the patient, incorporating lifestyle modifications alone, the patient was able to reduce the triglycerides from an average of 44.94 mmol/L to 3.28 mmol/L.</p>","PeriodicalId":73805,"journal":{"name":"Journal of lifestyle medicine","volume":"11 1","pages":"43-46"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/d7/jlm-11-1-43.PMC7957042.pdf","citationCount":"1","resultStr":"{\"title\":\"Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (> 14 mmol/L) and Triglycerides (> 40 mmol/L).\",\"authors\":\"Janhavi Patel,&nbsp;Tanmya Sharma,&nbsp;Connor Allan,&nbsp;Gregory Curnew\",\"doi\":\"10.15280/jlm.2021.11.1.43\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this report, we describe a case of a 37-year old man who presented with a history of total cholesterol > 14 mmol/L and triglyceride levels > 40 mmol/L. The patient was initially thought to have familial hypercholesterolemia due to his elevated total cholesterol, by his family physician. He was prescribed evolucumab, a proprotein convertase subtilisin/ kexin type 9 inhibitor drug which has shown efficacy for lowering low-density lipoprotein-cholesterol levels, to reduce his high total cholesterol. However, in this patient, the elevated total cholesterol was likely due to hypertriglyceridemia, rather than increased low-density lipoprotein-cholesterol levels. Through this case we provide an approach for the clinical management of patients with elevated total cholesterol with underlying triglycerides ≥ 10 mmol/L. The primary intervention for management of triglycerides ≥ 10 mmol/L involves lifestyle modifications including, changes in diet, exercise, reduction in body mass index, and abstinence from alcohol consumption. Secondary intervention involves management through pharmacotherapy with fibrates and statins. Creating a plan of action with the patient, incorporating lifestyle modifications alone, the patient was able to reduce the triglycerides from an average of 44.94 mmol/L to 3.28 mmol/L.</p>\",\"PeriodicalId\":73805,\"journal\":{\"name\":\"Journal of lifestyle medicine\",\"volume\":\"11 1\",\"pages\":\"43-46\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/d7/jlm-11-1-43.PMC7957042.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of lifestyle medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15280/jlm.2021.11.1.43\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of lifestyle medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15280/jlm.2021.11.1.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

在这个报告中,我们描述了一个37岁男性的病例,他的总胆固醇> 14 mmol/L,甘油三酯水平> 40 mmol/L。由于患者总胆固醇升高,家庭医生最初认为患者患有家族性高胆固醇血症。医生给他开了evolucumab,这是一种蛋白转化酶枯草杆菌素/克辛蛋白9型抑制剂药物,对降低低密度脂蛋白胆固醇水平有效,从而降低他的高总胆固醇。然而,在该患者中,总胆固醇升高可能是由于高甘油三酯血症,而不是低密度脂蛋白-胆固醇水平升高。通过本病例,我们为甘油三酯≥10 mmol/L的总胆固醇升高患者的临床管理提供了一种方法。管理甘油三酯≥10 mmol/L的主要干预措施包括改变生活方式,包括改变饮食、运动、降低体重指数和戒酒。二级干预包括通过贝特类药物和他汀类药物治疗。与患者一起制定行动计划,仅结合生活方式的改变,患者能够将甘油三酯从平均44.94 mmol/L降低到3.28 mmol/L。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (> 14 mmol/L) and Triglycerides (> 40 mmol/L).

In this report, we describe a case of a 37-year old man who presented with a history of total cholesterol > 14 mmol/L and triglyceride levels > 40 mmol/L. The patient was initially thought to have familial hypercholesterolemia due to his elevated total cholesterol, by his family physician. He was prescribed evolucumab, a proprotein convertase subtilisin/ kexin type 9 inhibitor drug which has shown efficacy for lowering low-density lipoprotein-cholesterol levels, to reduce his high total cholesterol. However, in this patient, the elevated total cholesterol was likely due to hypertriglyceridemia, rather than increased low-density lipoprotein-cholesterol levels. Through this case we provide an approach for the clinical management of patients with elevated total cholesterol with underlying triglycerides ≥ 10 mmol/L. The primary intervention for management of triglycerides ≥ 10 mmol/L involves lifestyle modifications including, changes in diet, exercise, reduction in body mass index, and abstinence from alcohol consumption. Secondary intervention involves management through pharmacotherapy with fibrates and statins. Creating a plan of action with the patient, incorporating lifestyle modifications alone, the patient was able to reduce the triglycerides from an average of 44.94 mmol/L to 3.28 mmol/L.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Effect of Gratitude on the Mental Health of Healthcare Workers as Measured by Burnout and Depression. Symposium Commemorating the 10th Anniversary of the Korean Society of Lifestyle Medicine. Association between Eating Disorders, Academic Stress with Menstrual Dysfunction among College Female Students: A Cross-Sectional Study. Accelerated Muscle Strength Decline and Reduced Lean Mass in Adults with Treated Inflammatory Bowel Disease: A NHANES Study. Illuminating Insomnia: A Scientometric Exploration of Complementary and Alternative Medicine in Treatment Research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1